ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹881 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹285 Cr |
| Mar2022 | ₹269 Cr |
| Mar2021 | ₹292 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹881 Cr | 860.69 | |
| Mar2024 | ₹92 Cr | -67.77 | |
| Mar2023 | ₹285 Cr | 5.93 | |
| Mar2022 | ₹269 Cr | -7.89 | |
| Mar2021 | ₹292 Cr | - | |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹70,085.0 Cr | 1.2% | 4.1% | 7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 1.2% |
4.1% |
7.7% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses